IFS named a Leader in two IDC MarketScape 2024-2025 Vendor Assessments: Manufacturing ERP and Remanufacturing Management Software

2025-02-13 IDOPRESS

LONDON,Feb. 12,2025 -- IFS,the leading enterprise cloud and Industrial AI software provider,announces that it has been positioned as a Leader in two IDC MarketScape reports: the IDC MarketScape: Worldwide SaaS and Cloud-Enabled Manufacturing ERP Applications 2024–2025 Vendor Assessment (doc #US51752524,December 2024),and the IDC MarketScape: Worldwide Remanufacturing Management Software 2024 Vendor Assessment (doc #US51036724,September 2024).

The IDC MarketScape report for Worldwide SaaS and Cloud-Enabled Manufacturing ERP Applications noted,"IFS is focused on six industries (and their subindustries) and has the technology and capabilities (i.e.,industry-specific next-gen capabilities) to cater to their unique needs. It includes standard industry-specific dashboards with a line-of-business (LOB) process flow."

Similarly,the IDC MarketScape report for Worldwide Remanufacturing Management Software evaluates vendors based on a comprehensive set of criteria,including product capabilities,go-to-market strategy,and business execution. The report for remanufacturing management software noted,"If you are looking for a comprehensive remanufacturing suite that addresses cost and operations management while being fully embedded within IFS' cloud manufacturing offering,consider working with IFS. Consider IFS if you are looking for a solution that is being continuously developed and enhanced with features to keep up with market requirements."

Max Roberts,Chief Operations Officer at IFS,said: "IFS is deeply proud of our industry focused approach to technology and Industrial AI innovation. We believe it is critical to continue to invest in developing innovative and flexible solutions that meet the evolving needs of the manufacturing industry,enabling efficiency and success in their end-to-end operations."

The IDC MarketScape reports evaluate vendors based on a rigorous scoring methodology that includes both qualitative and quantitative criteria.

Contact Information


EMEA / APJ: Adam Gillbe


IFS,Director of Corporate & Executive Communications


Email: adam.gillbe@ifs.com

NORTH AMERICA / LATAM: Mairi Morgan


IFS,Director of Corporate & Executive Communications


Email: mairi.morgan@ifs.com

This information was brought to you by Cision http://news.cision.com

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map